[概述]二　决奈达隆

Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg bid for the Prevention of Cardiovascular Hospital-ization or Death from any Cause in Patientswith Atrial Fibrillation/Atrial Flutter ）研究表明，服用决奈达隆明显降低心律失常死亡率。ATHENA研究的事后分析表明，决奈达隆和卒中风险降低有关。原因可能 ......